{"version":"1.0","provider_name":"The Medical Xchange","provider_url":"https:\/\/themedicalxchange.com\/fr\/","title":"Un PCSK9i ma\u00eetrise durablement la concentration de C-LDL d\u2019une population probl\u00e9matique de patients, tout en restant s\u00fbr - The Medical Xchange","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"OfJ23r8b2K\"><a href=\"https:\/\/themedicalxchange.com\/fr\/2015\/09\/10\/congres-de-2015-de-la-sec\/\">Un PCSK9i ma\u00eetrise durablement la concentration de C-LDL d\u2019une population probl\u00e9matique de patients, tout en restant s\u00fbr<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/themedicalxchange.com\/fr\/2015\/09\/10\/congres-de-2015-de-la-sec\/embed\/#?secret=OfJ23r8b2K\" width=\"600\" height=\"338\" title=\"\u00ab\u00a0Un PCSK9i ma\u00eetrise durablement la concentration de C-LDL d\u2019une population probl\u00e9matique de patients, tout en restant s\u00fbr\u00a0\u00bb &#8212; The Medical Xchange\" data-secret=\"OfJ23r8b2K\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/themedicalxchange.com\/wp-includes\/js\/wp-embed.min.js\n\/* ]]> *\/\n<\/script>\n","thumbnail_url":"https:\/\/themedicalxchange.com\/wp-content\/uploads\/2015\/09\/2349_SEC_2015_fr_Fig_1.PNG","thumbnail_width":960,"thumbnail_height":720,"description":"Londres \u2013 Lors d\u2019une d\u00e9monstration rigoureuse de son efficacit\u00e9 hypolip\u00e9miante, l\u2019inhibition de la PCSK9 a permis \u00e0 une majorit\u00e9 de patients atteints d\u2019hypercholest\u00e9rol\u00e9mie familiale h\u00e9t\u00e9rozygote (HF HTZ) de r\u00e9aliser leur objectif th\u00e9rapeutique. En revanche, peu de t\u00e9moins ayant re\u00e7u un placebo y sont parvenus, m\u00eame en suivant un traitement intensif \u00e0 l\u2019aide de statines. Les donn\u00e9es collig\u00e9es chez les patients atteints d\u2019HF HTZ, qui ont \u00e9t\u00e9 pr\u00e9sent\u00e9es pendant le congr\u00e8s de 2015 de la SEC, sont \u00e9galement applicables aux autres patients tr\u00e8s vuln\u00e9rables qui ne r\u00e9ussissent pas \u00e0 atteindre leur objectif th\u00e9rapeutique avec leur traitement actuel."}